Bristol-Myers signs HIV drug technology transfer agreement with Brazil
As per the agreement, Bristol-Myers will transfer the manufacture and distribution of its atazanavir sulfate 200 mg and 300 mg capsules to Brazilian Ministry of Health’s technical-scientific unit
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.